ADIE-BC - Aligning Dimensions of Interoceptive Experience in Breast Cancer Survivors

A breast cancer diagnosis can lead to significant anxiety, and for many survivors, this anxiety continues well beyond the end of treatment. While standard anxiety therapies are helpful for some, these therapies often fall short for breast cancer survivors due to an individual's unique experience-particularly changes in how survivors perceive and relate to the body, a process known as interoception. The study will evaluate the feasibility and acceptability of a novel interoceptive training approach called ADIE Therapy. ADIE Therapy trains participants to better recognise bodily signals, and has shown promising results in reducing anxiety in non-cancer populations. The aim of the study is to assess the acceptability and feasibility of ADIE Therapy for breast cancer survivors.

NCT Number	NCT06954532
Lead Sponsor	King's College London Collaborators: University College, London, Brighton & Sussex Medical School
Conditions	Cancer, Primary Breast Cancer
Enrollment	21 participants
Start Date	2025-06-13
Primary Completion	2025-12-18 (estimated)
Study Completion	2026-04-20 (estimated)
Updated on ClinicalTrials.gov	2026-04-23